Why do you need to give this medicine?
Used in the control of motion sickness.

ACTIVE INGREDIENT
Cinnarizine 25mg

ADDED INFORMATION
It contains the following excipients:
Lactose monohydrate, maize starch, sucrose, talc, magnesium stearate, povidone

INDICATION
Motion sickness

CONTRAINDICATION
Stugeron should not be given to patients with known hypersensitivity to cinnarizine or to any of the excipients

DOSAGE
Adults, elderly and children over 12 years:
2 tablets 2 hours before you travel and 1 tablet every 8 hours during your journey.
Children 5 to 12 years:
One half the adult dose

POSSIBLE SIDE EFFECT
Nausea, dyspepsia, vomiting, abdominal pain, weight gain, fatigue, muscle rigidity

CAUTION
As with other antihistamines, Stugeron may cause epigastric discomfort; taking it after meals may diminish gastric irritation.
In patients with Parkinson’s disease, Stugeron should only be given if the advantages outweigh the possible risk of aggravating this disease.
Use of cinnarizine should be avoided in porphyria.
There have been no specific studies in hepatic or renal dysfunction. Stugeron should be used with care in patients with hepatic or renal insufficiency.
Patients with rare hereditary problems of fructose or galactose intolerance, the Lapp lactase deficiency, glucose-galactose malabsorption or sucrase- isomaltase insufficiency, should not take this medicine because it contains lactose and sucrose.
Stugeron may cause somnolence, especially at the start of treatment. Therefore caution should be taken when alcohol, central nervous system (CNS) depressants or tricyclic antidepressants are used concomitantly. Please also refer to section 4.5 Interactions with Other Medicinal Products and Other Forms of Interaction.

STORAGE
Keep out of the sight and reach of children.
Do not use after the end of the month shown as an expiry date on the packaging.
There are no special storage conditions for this product.